Australian antiviral drug development company Island Pharmaceuticals (ASX:ILA) has announced new data that are expected to introduce significant, quantifiable time and cost savings into its clinical program for dengue fever. …
Island Pharmaceuticals says new data leads to ISLA-101 Phase 2 study changes
June 3, 2024 Australian Biotech
Latest Video
New Stories
-
New technology hits Australia for type 1 diabetes patients
March 12, 2025 - - Latest News -
'What I love about this event is that it brings together a community of people who otherwise feel quite isolated'
March 11, 2025 - - Latest News -
The terrible events of 2023 were born of a decade-old policy failure
March 11, 2025 - - Latest News -
New report reveals scathing patient assessment of Pharmac's culture
March 11, 2025 - - Latest News -
The key is leading with good ideas that will make the system better
March 11, 2025 - - Latest News -
Total continues to grow as AstraZeneca and Alexion maintain lead
March 10, 2025 - - Latest News -
Anatara Lifesciences updates on GaRP-Irritable Bowel Syndrome trial
March 10, 2025 - - Australian Biotech